Bicocca Open Archive

Logo unimib boa
FRUSCIO, ROBERT
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.344
EU - Europa 6.232
AS - Asia 2.335
SA - Sud America 74
AF - Africa 30
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 23
Totale 24.063
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.081
IT - Italia 1.499
CN - Cina 1.295
IE - Irlanda 1.158
SE - Svezia 872
DE - Germania 860
UA - Ucraina 628
HK - Hong Kong 520
GB - Regno Unito 401
CA - Canada 242
FI - Finlandia 178
VN - Vietnam 134
FR - Francia 130
IN - India 125
TR - Turchia 99
AT - Austria 85
DK - Danimarca 79
RU - Federazione Russa 74
NL - Olanda 54
BE - Belgio 52
ES - Italia 51
JP - Giappone 44
BR - Brasile 26
IR - Iran 26
CH - Svizzera 22
AU - Australia 20
SK - Slovacchia (Repubblica Slovacca) 19
CO - Colombia 18
PL - Polonia 18
MX - Messico 17
EG - Egitto 15
EU - Europa 15
SG - Singapore 15
BG - Bulgaria 12
KR - Corea 12
PH - Filippine 11
CL - Cile 10
TH - Thailandia 10
A2 - ???statistics.table.value.countryCode.A2??? 8
GR - Grecia 8
PE - Perù 8
RO - Romania 8
TW - Taiwan 8
CZ - Repubblica Ceca 7
PT - Portogallo 7
AR - Argentina 5
ID - Indonesia 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
IL - Israele 4
MY - Malesia 4
VE - Venezuela 4
GT - Guatemala 3
HR - Croazia 3
LK - Sri Lanka 3
MD - Moldavia 3
PK - Pakistan 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BO - Bolivia 2
KZ - Kazakistan 2
MZ - Mozambico 2
RS - Serbia 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
IQ - Iraq 1
KH - Cambogia 1
LU - Lussemburgo 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
NP - Nepal 1
SN - Senegal 1
UY - Uruguay 1
Totale 24.063
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.294
Woodbridge 1.570
Fairfield 1.493
Dublin 1.104
Houston 1.061
Chandler 948
Ashburn 823
Wilmington 815
Jacksonville 685
Seattle 616
Frankfurt am Main 575
Cambridge 518
Hong Kong 495
Dearborn 488
New York 466
Princeton 426
Milan 307
Hangzhou 217
Nanjing 204
Lawrence 191
Altamura 170
Beijing 167
Shanghai 127
Lachine 112
San Diego 100
Vienna 83
Lissone 81
Nanchang 77
Boardman 74
Andover 62
Ottawa 60
Dong Ket 56
Guangzhou 55
Fremont 52
London 52
Shenyang 52
Helsinki 49
Hebei 44
Rome 40
Toronto 40
Brussels 38
Changsha 38
Falls Church 34
Jinan 33
Kunming 33
Norwalk 31
Los Angeles 30
Jiaxing 28
Tianjin 28
Pune 27
Huizen 25
Chicago 24
Redmond 21
Bratislava 18
Hefei 18
Istanbul 17
Carate Brianza 16
Florence 16
Monza 16
Padova 16
Mountain View 15
Edmonton 14
Ningbo 14
Washington 14
Leawood 13
San Mateo 13
Bonndorf 12
Desio 12
Taizhou 12
Turin 12
Amsterdam 11
Kilburn 11
Lanzhou 11
Zhengzhou 11
Lappeenranta 10
Antalya 9
Brescia 9
Madrid 9
Trieste 9
Cairo 8
Chongqing 8
Hanoi 8
Kiev 8
Melbourne 8
Menlo Park 8
Paris 8
Perugia 8
Tappahannock 8
Tokyo 8
Verona 8
Wuhan 8
Baltimore 7
Bari 7
Bergamo 7
Caserta 7
Chengdu 7
Chiswick 7
Gainesville 7
Hyderabad 7
Mexico City 7
Totale 18.736
Salva come PNG Salva come JPEG
Nome #
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group 387
Management and outcome of colorectal cancer during pregnancy: report of 41 cases 332
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 332
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 302
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study 299
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 283
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 273
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 264
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 251
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 225
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 213
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 211
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study 195
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 194
Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations 192
Iliococcygeus fixation or abdominal sacral colpopexy for the treatment of vaginal vault prolapse: a retrospective cohort study 191
Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in endometrial cancer according to the International Endometrial Tumor Analysis (IETA) criteria 187
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancy 186
Characteristics of patients with cervical cancer during pregnancy: A multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy 186
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer 185
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 185
GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study 178
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 177
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 176
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 176
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 174
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 172
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 169
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 168
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer 168
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model 166
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 165
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 164
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers 159
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 158
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review 157
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 157
Imaging in gynecological disease (16): clinical and ultrasound characteristics of serous cystadenofibromas in adnexa 157
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy 157
601: Cisplatin response in a panel of patient-derived ovarian carcinoma xenografts: roles of epithelial mesenchymal transition and DNA repair 156
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype 155
Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses 155
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 153
Managing Ovarian tumors during pregnancy 153
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 153
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series 152
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 151
PRL-3 phosphatase is implicated in ovarian cancer growth 149
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 148
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 148
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma 147
The Zinc Finger Gene ZIC2 Has Features of an Oncogene and Its Overexpression Correlates Strongly with the Clinical Course of Epithelial Ovarian Cancer 146
External validation of diagnostic models to estimate the risk of malignancy in adnexal masses 145
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 145
Clinical utility of risk modelsto refer patients with adnexal masses to specialized oncology care: Multicenter external validation using decision curve analysis 144
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 143
Ovarian Carcinoma Xenografts–Drug Response and Molecular Characterization 141
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 138
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein 137
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 136
Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies 136
Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumour Analysis) 4 cohort 136
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 136
Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients 133
Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts 129
Synchronous early-stage endometrial and ovarian cancer 128
Delaying surgery for patients with a previous SARS-CoV-2 infection 128
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients 126
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help 125
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition 125
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 125
Ultrasound characteristics of endometrial cancer as defined by the International Endometrial Tumor Analysis (IETA) consensus nomenclature - A prospective multicenter study 124
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 122
925pmatched cohort study on patients with cervical cancer diagnosed during pregnancy 121
Prognosis of patients with cervical cancer diagnosed during pregnancy 121
Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer 119
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities 119
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts 119
Ovarian cancer prediction in adnexal masses using ultrasound based logistic regression models: a temporal and external validation study by the IOTA group 118
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 117
The role of transvaginal ultrasound in the workup of invasive molar disease 116
Melanoma during pregnancy: A report of 60 pregnancies complicated by melanoma 116
Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting 116
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers 116
Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy 116
DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer 115
Platinum, anthracycline, and alkylating agent-based chemotherapy for ovarian carcinosarcoma 114
Prognostic factors for recurrence and survival among patients with invasive vulvar Paget disease included in the VULCAN study 114
The impact of DNA damage response gene polymorphisms on therapeutic outcomes in late stage ovarian cancer 113
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 112
Ultrasound-based risk model for preoperative prediction of lymph-node metastases in women with endometrial cancer: model-development study 112
Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment 111
Effect of cancer prevalence on the use of risk-assessment cut-off levels and the performance of mathematical models to distinguish malignant from benign adnexal masses 111
Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations 111
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 111
Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy 111
Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery 110
Somministrazione settimanale di cisplatino in pazienti con carcinoma ovarico in stadio avanzato: risultati a lungo termine di uno studio clinico randomizzato 110
Harmonic scalpel versus conventional electrosurgery in the treatment of vulvar cancer 110
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 110
Totale 15.928
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.783
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.220 0 0 0 0 0 0 0 0 0 244 503 473
2019/20204.762 563 222 316 445 438 582 656 362 507 256 280 135
2020/20214.136 224 177 332 423 326 355 427 496 374 424 226 352
2021/20222.629 205 226 211 250 149 252 121 147 139 254 218 457
2022/20234.327 475 1.202 357 329 253 688 118 247 326 44 162 126
2023/20243.646 127 142 238 269 503 948 776 184 352 107 0 0
Totale 25.181